LV12045B - METHOD OF N-MONO-FUELED AND N, N'-DOUBLE-SELECTED NON-METHODS OF CYCLIC CYCLING \ t - Google Patents

METHOD OF N-MONO-FUELED AND N, N'-DOUBLE-SELECTED NON-METHODS OF CYCLIC CYCLING \ t Download PDF

Info

Publication number
LV12045B
LV12045B LVP-97-248A LV970248A LV12045B LV 12045 B LV12045 B LV 12045B LV 970248 A LV970248 A LV 970248A LV 12045 B LV12045 B LV 12045B
Authority
LV
Latvia
Prior art keywords
substituted
groups
group
alkyl
benzyl
Prior art date
Application number
LVP-97-248A
Other languages
English (en)
Latvian (lv)
Other versions
LV12045A (lv
Inventor
James David Rodgers
Jung-Hui Sun
Original Assignee
Dupont Pharmaceuticals Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dupont Pharmaceuticals Company filed Critical Dupont Pharmaceuticals Company
Publication of LV12045A publication Critical patent/LV12045A/xx
Publication of LV12045B publication Critical patent/LV12045B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
LVP-97-248A 1995-06-07 1998-01-28 METHOD OF N-MONO-FUELED AND N, N'-DOUBLE-SELECTED NON-METHODS OF CYCLIC CYCLING \ t LV12045B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/481,683 US5532357A (en) 1995-06-07 1995-06-07 Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
PCT/US1996/009021 WO1996040652A1 (en) 1995-06-07 1996-06-06 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas

Publications (2)

Publication Number Publication Date
LV12045A LV12045A (lv) 1998-05-20
LV12045B true LV12045B (en) 1998-09-20

Family

ID=23912954

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-248A LV12045B (en) 1995-06-07 1998-01-28 METHOD OF N-MONO-FUELED AND N, N'-DOUBLE-SELECTED NON-METHODS OF CYCLIC CYCLING \ t

Country Status (26)

Country Link
US (1) US5532357A (et)
EP (2) EP1029859A1 (et)
JP (1) JPH11506779A (et)
KR (1) KR19990022467A (et)
CN (1) CN1192209A (et)
AR (1) AR002384A1 (et)
AU (1) AU704535B2 (et)
BR (1) BR9609493A (et)
CA (1) CA2223391A1 (et)
CZ (1) CZ381997A3 (et)
EA (1) EA000363B1 (et)
EE (1) EE9700330A (et)
HR (1) HRP960259A2 (et)
HU (1) HUP9900913A2 (et)
IL (1) IL122424A0 (et)
LT (1) LT4381B (et)
LV (1) LV12045B (et)
MX (1) MX9709652A (et)
NO (1) NO975679L (et)
NZ (1) NZ309648A (et)
PL (1) PL323993A1 (et)
SI (1) SI9620077A (et)
SK (1) SK164397A3 (et)
TW (1) TW358091B (et)
WO (1) WO1996040652A1 (et)
ZA (1) ZA964847B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US6054597A (en) * 1995-11-14 2000-04-25 Dupont Pharmaceuticals Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
US6218386B1 (en) 1996-11-08 2001-04-17 Dupont Pharmaceuticals A1-(3-aminoindazol-5-yl)-3 butyl-cyclic urea useful as a HIV protease inhibitor
CZ157599A3 (cs) * 1996-11-08 1999-11-17 Du Pont Pharmaceuticals Company 1-(3-Aminoindazol-5-yl)-3-fenylmethylcyklické močoviny použitelné jako inhibitory HIV
US5932570A (en) * 1996-11-08 1999-08-03 Dupont Pharmaceuticals Company 1-(3-aminoindazol-5-yl)-3-phenylmethyl-cyclic ureas useful as HIV protease inhibitors
WO1998043969A1 (en) * 1997-03-31 1998-10-08 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
US6218534B1 (en) 1997-10-06 2001-04-17 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate
EP1091944A1 (en) 1998-06-30 2001-04-18 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
EP1183242A2 (en) 1999-05-26 2002-03-06 Du Pont Pharmaceuticals Company 1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
US6313110B1 (en) * 1999-06-02 2001-11-06 Dupont Pharmaceuticals Company Substituted 2H-1,3-diazapin-2-one useful as an HIV protease inhibitor
FR2810039B1 (fr) * 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation
AU2002258633A1 (en) * 2001-03-28 2002-10-15 Bristol-Myers Squibb Company Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
US20080033167A1 (en) * 2005-12-29 2008-02-07 Gilles Guichard Compositions and methods for synthesizing heterocyclic therapeutic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
WO1993007128A1 (en) * 1991-10-11 1993-04-15 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors
US5430043A (en) * 1993-08-24 1995-07-04 G. D. Searle & Co. Platelet aggregation inhibitors
US5530124A (en) * 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5466797A (en) * 1994-06-30 1995-11-14 The Du Pont Merck Pharmaceutical Company Intermediates for the preparation of cyclic urea
US5532356A (en) * 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US7344671B2 (en) 2003-11-26 2008-03-18 Glopak Inc. Optical sealing clamp and a method for sealing and cutting polymeric sheets with a laser
US7369013B2 (en) 2005-04-06 2008-05-06 Avago Technologies Wireless Ip Pte Ltd Acoustic resonator performance enhancement using filled recessed region

Also Published As

Publication number Publication date
BR9609493A (pt) 1999-03-02
PL323993A1 (en) 1998-04-27
AR002384A1 (es) 1998-03-11
AU5986896A (en) 1996-12-30
LV12045A (lv) 1998-05-20
EE9700330A (et) 1998-06-15
EP1029859A1 (en) 2000-08-23
SK164397A3 (en) 2000-04-10
US5532357A (en) 1996-07-02
IL122424A0 (en) 1998-06-15
EA000363B1 (ru) 1999-06-24
TW358091B (en) 1999-05-11
CA2223391A1 (en) 1996-12-19
WO1996040652A1 (en) 1996-12-19
NO975679L (no) 1998-02-02
LT97188A (en) 1998-04-27
EP0837855A1 (en) 1998-04-29
EP0837855A4 (en) 1998-09-02
LT4381B (lt) 1998-09-25
HRP960259A2 (en) 1997-10-31
NO975679D0 (no) 1997-12-05
CZ381997A3 (cs) 1999-01-13
KR19990022467A (ko) 1999-03-25
ZA964847B (en) 1997-12-08
MX9709652A (es) 1998-03-29
AU704535B2 (en) 1999-04-29
NZ309648A (en) 1998-09-24
EA199800034A1 (ru) 1998-08-27
JPH11506779A (ja) 1999-06-15
HUP9900913A2 (hu) 1999-09-28
CN1192209A (zh) 1998-09-02
SI9620077A (sl) 1998-08-31

Similar Documents

Publication Publication Date Title
DE69425135T2 (de) Substituierte cyclische carbonylderivate und analoga verwendbar als retrovirale proteasehemmer
LV12045B (en) METHOD OF N-MONO-FUELED AND N, N'-DOUBLE-SELECTED NON-METHODS OF CYCLIC CYCLING \ t
WO2018225018A1 (en) Novel substituted sulfoximine compounds
EP0830349B1 (en) Method for preparing n, n'-disubstitued cyclic ureas
TWI766484B (zh) 化合物
WO1997008150A1 (en) Substituted cyclic ureas and derivatives thereof useful as retroviral protease inhibitors
US5508400A (en) Preparation of cyclic urea compounds
TWI768781B (zh) 轉化生長因子－β受體抑制劑
US5530124A (en) Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5710286A (en) Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
US6054597A (en) Processes and intermediates for the preparation of cyclic urea HIV protease inhibitors
JP6757332B2 (ja) ＲＯＲｃモジュレーターとしてのピリダジン誘導体
TW202304434A (zh) 一種高活性的ｈｐｋ１激酶抑制劑